Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Malignant Prostate Neoplasm

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Malignant Prostate Neoplasm

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 1 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null

      Study evidence for this setting

      10 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00417079 · Source cited / selected · Scope: narrower

      XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT00638690 · Source cited / selected · Scope: narrower

      Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

      4 outcome links · 3 safety-group records · 0 quality-of-life measures

      →

      NCT01288911 · Source cited / selected · Scope: narrower

      A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

      6 outcome links · 4 safety-group records · 0 quality-of-life measures

      →

      NCT01715285 · Source cited / selected · Scope: narrower

      A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-

      6 outcome links · 3 safety-group records · 1 quality-of-life measures

      →

      NCT01946204 · Source cited / selected · Scope: narrower

      A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT02234115 · Source cited / selected · Scope: narrower

      Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma

      2 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT03685591 · Registry condition search · Scope: narrower

      PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

      6 outcome links · 9 safety-group records · 0 quality-of-life measures

      →

      NCT03693742 · Registry condition search · Scope: narrower

      MSG Use With 18F-DCFPyL PET/CT Imaging

      4 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT04066894 · Registry condition search · Scope: narrower

      Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

      6 outcome links · 1 safety-group records · 3 quality-of-life measures

      →

      NCT04689828 · Source cited / selected · Scope: narrower

      177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer

      6 outcome links · 2 safety-group records · 3 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-malignant-prostate-neoplasm
        binding id
        ncit-C7378
        source collection
        ncit-concept
        source key
        C7378
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice